Skip to main content
Registrieren
Springer Medizin Österreich
SUCHE
MENÜ 1 2 3 4
nach oben

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2015

01.09.2015 | Case report

A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years

A patient with somatic type malignancy

verfasst von: MD Andreas Edwin Juarso, MD Malte Kiehl, MD Olaf Pfennig, MD Günther Wittenberg, MD Florian Weissinger

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten
share
TEILEN

Abstract

A 59-year-old patient presented in the outpatient clinic because of an increasing mass in his right buttock. He has a history of a testicular tumor 28 years ago, with increased tumor markers (Human Choriongonadotropin (β-HCG) value 4.9 and Alpha-1 Fetoprotein (AFP) 218 ng/ml).
Vorheriger Artikel Prognostic factors and their correlation with staging in patients with multiple myeloma: a single centre study in North India
Nächster Artikel Notes on breast cancer prevention and screening
Literatur
1.
Collins DH, Pugh RC. Classification and frequency of testicular tumours. Br J Urol. 1964;36:1–11. CrossRefPubMed
2.
Winter E, Kliesch S, Souchon R, de Maike W. Diagnosis of testicular cancer. Dtsch Arztebl. 2005;102:A 3021–5 (Heft 44).
3.
Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79. CrossRefPubMed
4.
Stamatiou K, Papadopoulos P, Perlepes G, Galariotis N, Olympitis M, Moschouris H, Vasilakaki T. Mixed germ tumor of the testicle with ravdomuosarcomatous component: a case report. Cases J. 2009;2:9299. PubMedCentralCrossRefPubMed
5.
Krege S, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol. 2008;53(3):478–96. CrossRefPubMed
6.
Hanna NH, Einhorn LH. Testicular cancer—discoveries and updates. N Engl J Med. 2014;371:2005–16. CrossRefPubMed
7.
Krege S, Albers P, Schmidberger H. Treatment of non-metastatic and moderate metastatic testicular cancer. Dtsch Arztebl. 2005;102:A 3191–4 (Heft 46).
8.
Bokemeyer C, Beyer J, Heidenreich A. Treatment of patients with metastatic germ cell tumors. Dtsch Arztebl. 2005;102:A 3271–5 (Heft 47).
9.
Pottek TS, Hartmann M, Bokemeyer C. Aftercare and delayed toxicity of testicular cancer. Dtsch Arztebl. 2005;102:A 3342–8 (Heft 48).
10.
Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol. 1997;8(1):41–7. CrossRefPubMed
11.
Oldenburg J, Alfsen GC, Waehre H, Fossá SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer. 2006;94(6):820–7. PubMedCentralCrossRefPubMed
12.
Geldart TR, Gale J, McKendrick J, Kirby J, Mead G. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int. 2006;98(2):353–8. CrossRefPubMed
13.
Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol. 2005;23(28):6999–7004. CrossRefPubMed
14.
Krege S, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol. 2008;53(3):497–513. CrossRefPubMed
15.
Arafat W, Albany C, Ulbright TM, Foster R, Einhorn LH. Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature. J Surg Case Rep. 2014;2014(6):rju051. PubMedCentralCrossRefPubMed
16.
Pavic M, Meeus P, Treilleux I, Droz JP. Malignant teratoma 32 years after treatment of germ cell tumor confined to testis. Urology. 2006;67(4):846. CrossRefPubMed
17.
18.
Bilici A, Ustaalioglu BB, Seker M, Kayahan S. Soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature. Clin Orthop Relat Res. 2010;468(9):2541–4. PubMedCentralCrossRefPubMed
19.
Oosterhuis JW, Peeters SH, Smit VT, Stoop H, Looijenga LH, Elzevier HW, Osanto S. Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept. Int J Dev Biol. 2013;57(2–4):153–7. CrossRefPubMed
20.
Zeh N, Wild PJ, Bode PK, Kristiansen G, Moch H, Sulser T, Hermanns T. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumor metastasis following platinum-based chemotherapy. BMC Urol. 2013;13:9. PubMedCentralCrossRefPubMed
21.
Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2013;31(30):3807–14. PubMedCentralCrossRefPubMed
22.
Mesbahi O E, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol. 2007;51(5):1306–11. CrossRefPubMed
23.
Vaughn DJ, Hwang W, Lal P, Rosen MA, Gallagher M, O’Dwyer PJ. Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors. Cancer. 2015;121(9):1463–8. CrossRefPubMed
Metadaten
Titel
A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years
A patient with somatic type malignancy
verfasst von
MD Andreas Edwin Juarso
MD Malte Kiehl
MD Olaf Pfennig
MD Günther Wittenberg
MD Florian Weissinger
Publikationsdatum
01.09.2015
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-015-0222-8

Weitere Artikel der Ausgabe 3/2015

memo - Magazine of European Medical Oncology 3/2015 Zur Ausgabe

short review

ASH 2014 highlights: new therapeutic concepts for T cell lymphomas

editorial

“Just because your doctor has a name for your condition doesn’t mean he knows what it is.” Bertrand Russell

short review

Indolent lymphoma at ASH 2014: new kids on the block (iDrugs)

comment

Notes on breast cancer prevention and screening

short review

Changing treatment paradigms in lymphoma: new targets and new drugs

short review

ASH 2014: novel strategies in the management of classical Hodgkin’s lymphoma